Sonitus Medical, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sonitus Medical, Inc. - overview
Established
2006
Location
San Mateo, CA, US
Primary Industry
Medical Devices & Equipment
About
Sonitus Medical, Inc. develops innovative auditory solutions, focusing on non-invasive hearing aids designed specifically for individuals with conductive hearing loss, ensuring a personalized auditory experience. Founded in 2006 and headquartered in San Mateo, US, Sonitus Medical, Inc. specializes in auditory solutions, including its flagship product, the SoundBite device.
The company was established by Amir Abolfathi, who has a background in developing medical technology. Sonitus Medical secured a total of USD 10. 22 mn in funding through its recent Series D round, which was completed on August 24, 2022, involving investors like Abingworth and Arboretum Ventures. This amount reflects the total raised by the company, valuing it at USD 112.
31 mn. Sonitus Medical specializes in innovative solutions for hearing impairment with its flagship product, the Sonitus SoundBite, a unique oral device designed for individuals with conductive hearing loss. This product utilizes bone conduction and audio transmission to deliver sound directly to the inner ear through the teeth, targeting adults with specific hearing deficits who prefer a discreet alternative to traditional hearing aids. SoundBite has gained traction among audiologists and consumers in North America and select European markets.
The company emphasizes education for healthcare professionals to enhance product adoption. Sonitus Medical generates revenue through direct sales of its SoundBite device, primarily marketed through partnerships with audiologists and hearing care professionals. This B2B transaction structure enables healthcare providers to offer the product directly to consumers in their practices, with pricing plans accommodating both one-time purchases and subscription services for ongoing support. This business model aligns with the company’s goals of enhancing patient care and ensuring accessibility for users.
In August 2022, Sonitus Medical, Inc. announced the discontinuation of its operations, which affects its future product development and market expansion plans. As such, specific upcoming products, geographic expansion, or the utilization of recent funding for future initiatives are not currently in place.
Current Investors
RWI Ventures, Aberdare Ventures, Novartis Venture Fund
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.sonitusmedical.com
Company Stage
Ceased Operations
Total Amount Raised
Subscriber access only
Sonitus Medical, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.